Exactech’s new knee arthroplasty device receives FDA clearance: 4 observations

Exactech received clearance from the FDA to market the Optetrak Logic Constrained Condylar Prosthesis.

Advertisement

Here are four observations:

 

1. The device is intended for use in revision knee arthroplasty cases. It is also indicated for when previous devices have failed.

 

2. The system aims to achieve optimal implant placement and bone coverage.

 

3. The Optetrak Logic CC system will have limited availability in 2015 and a full market launch in 2016.

 

4. Exactech is a medical device company focusing on solutions for hip, knee shoulder and spine surgery.

 

More articles on devices:
SIGNUS develops ASCOT for spinal fusion — 7 things to know
Tyber Medical launches lateral retractor system — 5 things to know
Simponi receives CE mark — 5 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.